Phase I Study of Mebendazole Therapy for Recurrent/Progressive Pediatric Brain Tumors
Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
A PHASE1 clinical study on Anaplastic Astrocytoma and Anaplastic Oligodendroglioma, this trial is completed. The trial is conducted by Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins and has accumulated 13 data snapshots since 2016. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
13 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE1
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jul 2022 — Jul 2024 [monthly]
Completed PHASE1
Status: Recruiting → Completed
-
Oct 2021 — Jul 2022 [monthly]
Recruiting PHASE1
▶ Show 8 earlier versions
-
Jan 2021 — Oct 2021 [monthly]
Recruiting PHASE1
-
Oct 2020 — Jan 2021 [monthly]
Recruiting PHASE1
-
Oct 2019 — Oct 2020 [monthly]
Recruiting PHASE1
-
Sep 2018 — Oct 2019 [monthly]
Recruiting PHASE1
-
Jun 2018 — Sep 2018 [monthly]
Recruiting PHASE1
-
Jun 2017 — Jun 2018 [monthly]
Recruiting PHASE1
-
Feb 2017 — Jun 2017 [monthly]
Recruiting PHASE1
-
Jan 2017 — Feb 2017 [monthly]
Recruiting PHASE1
First recorded
May 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
For direct contact, visit the study record on ClinicalTrials.gov .